Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms

Transplantation

Volumn 91, Issue 2, 2011, Pages 183-190

  Kosmoliaptsis, Vasilis ^a,b   Sharples, Linda D ^c   Chaudhry, Afzal N ^a   Halsall, David J ^a   Bradley, J Andrew ^b   Taylor, Craig J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Alloantigen immunogenicity; HLA antibodies; Kidney transplantation; Sensitization

Indexed keywords

ALLOANTIBODY; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ALLELE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; DNA POLYMORPHISM; FEMALE; HAPLOTYPE; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; KIDNEY TRANSPLANTATION; MALE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; FEMALE; HLA-D ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHYSICOCHEMICAL PHENOMENA; POLYMORPHISM, GENETIC; STATIC ELECTRICITY; YOUNG ADULT;

EID: 78751643078     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ffff99     Document Type: Article

References (27)

1. Opelz G, Dohler B. Effect of human leukocyte antigen compatibility on kidney graft survival: Comparative analysis of two decades. Transplantation 2007; 84: 137.
2. Fuggle SV, Johnson RJ, Rudge CJ, et al. Human leukocyte antigen and the allocation of kidneys from cadaver donors in the United Kingdom. Transplantation 2004; 77: 618.
3. Fuggle SV, Johnson RJ, Bradley JA, et al; on behalf of the Kidney Advisory Group of NHS Blood and Transplant. Impact of the 1998 UK National Allocation Scheme for deceased heartbeating donor kidneys. Transplantation 2010; 89: 372.
4. Johnson RJ, Fuggle SV, Mumford L, et al; on behalf of the Kidney Advisory Group of NHS Blood and Transplant. A New UK 2006 National Kidney Allocation Scheme for deceased heart-beating donor kidneys. Transplantation 2010; 89: 387.
5. Taylor CJ, Welsh KI, Gray CM, et al. Clinical and socio-economic benefits of serological HLA-DR matching for renal transplantation over three eras of immunosuppression regimens in a single unit. Clin Transpl 1993: 233.
6. Thorogood J, Persijn GG, Schreuder GM, et al. The effect of HLA matching on kidney graft survival in separate post transplantation intervals. Transplantation 1990; 50: 146.
7. Gilks WR, Gore SM, Bradley BA. Renal transplant rejection. Transient immunodominance of HLA mismatches. Transplantation 1990; 50: 141.
8. Duquesnoy RJ, Askar M. HLA Matchmaker: A molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. Hum Immunol 2007; 68: 12.
9. Duquesnoy RJ, Marrari M. HLA Matchmaker: A molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum Immunol 2002; 63: 353.
10. Dankers MK, Witvliet MD, Roelen DL, etal. The numberof amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation 2004; 77: 1236.
11. Goodman RS, Taylor CJ, O'Rourke CM, et al. Utility of HLAMatch-maker and single-antigen HLA antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation. Transplantation 2006; 81: 1331.
12. Kosmoliaptsis V, Bradley JA, Sharples LD, et al. Predicting the immuno-genicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker. Transplantation 2008; 85: 1817.
13. Kosmoliaptsis V, Chaudhry AN, Sharples LD, et al. Predicting HLA class I alloantigen immunogenicity from the number and physio-chemical properties of amino acid polymorphisms. Transplantation 2009; 88: 791.
14. Duquesnoy RJ. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 2002; 63: 339.
15. Duquesnoy RJ. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006; 67: 847.
16. Duquesnoy RJ, Takemoto S, de Lange P, et al. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A, B amino acid triplet level on kidney transplant survival. Transplantation 2003; 75: 884.
17. Duquesnoy R, Awadalla Y, Lomago J, et al. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR, DQ, DP epitopes. Transpl Immunol 2008; 18: 352.
18. Campos EF, Tedesco-Silva H, Machado PG, et al. Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure. Am J Transplant 2006; 6: 2316.
19. Issa N, Cosio FG, Gloor JM, et al. Transplant glomerulopathy: Risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation 2008; 86: 681.
20. Everly MJ, Everly JJ, Arend LJ, et al. Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss. Am J Transplant 2009; 9: 1063.
21. Lachmann N, Terasaki PI, Budde K, et al. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009; 87: 1505.
22. Doxiadis II, Smits JM, Schreuder GM, et al. Association between specific HLA combinations and probability of kidney allograft loss: The taboo concept. Lancet 1996; 348: 850.
23. Kosmoliaptsis V, Sharples LD, Chaudhry A, et al. HLA class I amino acid sequence based matching following inter-locus subtraction and long-term outcome after deceased donor kidney transplantation. Hum Immunol 2010; 71: 851.
24. Meier-Kriesche HU, Scornik JC, Susskind B, et al. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation 2009; 88: 23.
25. Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol 2007; 68: 779.
26. Taylor CJ. The HLA system and nomenclature. In: Morris PJ, ed. Kidney transplantation; principles and practice [ed. 5]. Philadelphia, W.B. Saunders Company 2001, pp 755.
27. Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Nat Acad Sci USA 1981; 78: 3824.